Skip to content

Prelude Therapeutics Inc

PRLD· Nasdaqxbrl foundCIK 1678660

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -7.12%
Market cap
$280.91M
79.8M shares
Filings
391
$5.70M
Q2 2026+73.4% FY25 yoy
-$13.92M
Q2 2026N/M FY25 yoy
-$15.45M
Q2 2026N/M FY25 yoy
-$37.26M
Q2 2026derivedN/M FY25 yoy
-$0.14
Q2 2026N/M FY25 yoy
$26.33M
Q2 2026+182.6% FY25 yoy
$280.91M
—
12.5×
2.1×
-11.84%
—

Twelve months to Jun 30, 2026 · derived

Price

$3.52+160.74%+$2.17past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$12.14MFY 2025
$12.14M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$12,140,000reported
FY 20242024-12-31$7,000,000reported

Pharmaceutical preparations

Prelude Therapeutics Inc is the 166th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Prelude Therapeutics Inc · CIK 1678660 · Engraved from SEC EDGAR